Literature DB >> 4390900

Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.

H S Shin, M R Smith, W B Wood.   

Abstract

When encapsulated type 25 pneumococci (Pn25) were opsonized with normal guinea pig serum, they consumed much more C3 than other complement (C) components. Fixation of C3 to the organisms was demonstrated by radio-labeling techniques, and its capsular localization was established by the use of monospecific anti-C3 antibody. Treatment of the serum with an appropriate dose of a purified cobra venom factor (VF) destroyed C3 and all of the opsonic activity, without appreciably affecting the other C components. Addition of purified C3 completely restored the opsonic activity of the VF-treated serum, indicating a requirement for C3. Since purified C3 alone had no opsonic activity, it was concluded that the C3 molecules had to be cleaved (to C3b) to function as opsonins. Experiments with C5-deficient mice revealed that C5 also plays a definite, but quantitatively less impressive, role in antipneumococcal defense.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4390900      PMCID: PMC2138700          DOI: 10.1084/jem.130.6.1229

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  STUDIES ON PHAGOCYTOSIS OF BACTERIA BY THE RETICULOENDOTHELIAL SYSTEM IN A STRAIN OF MICE LACKING HEMOLYTIC COMPLEMENT.

Authors:  C STIFFEL; G BIOZZI; D MOUTON; Y BOUTHILLIER; C DECREUSEFOND
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

3.  VARIANCE ESTIMATION IN THE REED-MUENCH FIFTY PER CENT END-POINT DETERMINATION.

Authors:  W F BROWN
Journal:  Am J Hyg       Date:  1964-01

4.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

5.  Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

Authors:  I Gigli; R A Nelson
Journal:  Exp Cell Res       Date:  1968-07       Impact factor: 3.905

6.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

7.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

8.  CORYNEBACTERIAL PSEUDOTUBERCULOSIS IN MICE. I. COMPARATIVE SUSCEPTIBILITY OF MOUSE STRAINS TO EXPERIMENTAL INFECTION WITH CORYNEBACTERIUM KUTSCHERI.

Authors:  C H PIERCE-CHASE; R M FAUVE; R DUBOS
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

9.  The role of complement in resistance to endogenous and exogenous infection with a common mouse pathogen, Corynebacterium kutscheri.

Authors:  L D Caren; L T Rosenberg
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis.

Authors:  R H Drachman; R K Root; W B Wood
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  29 in total

1.  Immunologic defense in bacterial and viral meningitis in children.

Authors:  J Ströder; R Seger
Journal:  Eur J Pediatr       Date:  1976-12-09       Impact factor: 3.183

2.  Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.

Authors:  C S Easmon; A A Glynn
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

3.  The effect of complement depletion on lung clearance of bacteria.

Authors:  G N Gross; S R Rehm; A K Pierce
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

Authors:  S I Rosenfeld; M E Kelly; J P Leddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

5.  Host defense against the pneumococcus in T-lymphocyte-deficient, nude mice.

Authors:  J A Winkelstein; A J Swift
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

6.  Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.

Authors:  H A Verbrugh; W C van Dijk; M E van Erne; R Peters; P K Peterson; J Verhoef
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

Review 7.  The role of phagocyte function in resistance to infection.

Authors:  R I Lehrer
Journal:  Calif Med       Date:  1971-06

Review 8.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

9.  A phagocytosis-enhancing factor in human plasma.

Authors:  I Gigli; B U Wintroub; E J Goetzl
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

10.  Alterations in serum opsonic activity and complement levels in pneumococcal disease.

Authors:  G S Giebink; T H Dee; Y Kim; P G Quie
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.